Company News
Collagen Solutions's losses narrow on improved top line performance
Biomaterials and regenerative medicines outfit Collagen Solutions expects to report narrowed pre-tax losses for the year ended 31 March, thanks to an improvement in revenues.
Debenhams lenders rebuff improved Sports Direct proposal
Mike Ashley's Sports Direct made an improved proposal to Debenhams on Tuesday morning, offering to underwrite a larger rights issue and reducing its demands for lenders to write off debt.
7Digital's appoints new leadership team
Digital music solutions provider 7digital's new leadership team were formally appointed to its board on Tuesday following the departure of long-time chief executive Simon Cole.
Avacta shares fall as interim revenues slide
Biotherapeutics and research reagents developer Avacta Group reported a fall in half-year revenues to £1. 0m on Tuesday, from £1. 5m a year earlier.
Destiny Pharma 'well funded' despite wider loss
Destiny Pharma on Tuesday reported a wider annual loss as it increased research and development costs, although the company is "well funded" through to the second half of next year.
Hipgnosis acquires Teddy Geiger interest in six Shawn Mendes songs
Hipgnosis Songs Fund has acquired a music catalogue of Teddy Geiger's copyright interest in six hit songs written for Shawn Mendes, it announced on Tuesday.
City Pub swings to profit amid expansion
City Pub said on Tuesday that it swung back to profit in 2018 as revenue grew amid the pub group's expansion.
Stride Gaming revenues fall short following fiscal and regulatory changes
Online gaming operator Stride expects net gaming revenues to have fallen short of expectations in the first half of its trading year as a result of greater disruption arising from fiscal and regulatory changes implemented in the second half of 2018.
CMA suspects trio of running construction sector cartel
Three major UK suppliers of groundworks products to the construction industry have been illegally running a price cartel for nearly two years, the competition watchdog said on Tuesday.
Hornby's full-year revenue to drop but losses set to narrow
Model train set maker Hornby said on Tuesday that revenue for the year to the end of March 2019 would be lower than last year due to stock shortages.
Cake Box sees full-year revenue up 30%
Cake Box, a specialist retailer of egg-free cream cakes, said on Tuesday that it expects to report a 30% jump in full-year revenue, while profits should be in line with current market expectations after strong trading.
AppScatter eyes reverse takeover of Airpush
App management and data intelligence platform provider AppScatter intends to acquire monetisation specialist Airpush as part of a reverse takeover.
Shearwater acquires Manchester-based cyber-security business
Digital resilience outfit Shearwater acquired cyber-security testing service Secarma for a total consideration of £7. 4m on Tuesday.
Novartis completes spin-off of Alcon eye care devices business
Novartis completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and American depositary receipts, it announced on Monday, with each holder receiving one Alcon share for every five Novartis shares or ADRs held on 8 April.
Verona Pharma gets another European patent on ensifentrine
Respiratory disease-focussed clinical stage biopharmaceutical company Verona Pharma announced on Tuesday that the European Patent Office had granted an additional key patent relating to its lead development candidate, ‘ensifentrine’.
Rough diamond sales at Anglo American's De Beers rise in third cycle
Anglo American said on Tuesday that the value of rough diamond sales at its De Beers unit rose in the third cycle of 2019.
Brewin Dolphin strengthens systems with Avaloq software agreement
Brewin Dolphin has signed an agreement with Avaloq UK to replace its core custody and settlement system, it announced on Tuesday.
Diageo in euro, sterling bond issues
Drinks maker Diageo on Tuesday said it was issuing €600m of fixed rate Euro and £500m of fixed rate sterling-denominated bonds under its European debt issuance programme.
GSK gets US green light for two-drug HIV treatment
GlaxoSmithkline said its two drug HIV treatment had been granted US market approval.